Nomic Bio
Latest round
- Series B
Last raised
- Sep 2024
Total raised
- $59M
Investors
- 6
About Nomic Bio
Founded in 2018 in Montreal, Canada, Nomic Bio focuses on innovative proteomics solutions. The leadership team is headed by CEO Milad Dagher, who, alongside co-founders Arya Tavakoli and Jeff Munzar, has been instrumental in the company's development.Nomic Bio offers high-throughput proteomics services centered around its flagship product, the nELISA, which utilizes DNA nanotechnology for scalable profiling of approximately 275 cytokines. This innovative approach allows clients to conduct flexible multiplexing of proteins, which is essential for understanding protein expression and interactions in various research contexts.The primary revenue stream for Nomic Bio comes from its nELISA services, which cater to B2B clients in the pharmaceutical and biotechnology sectors. The service model allows clients to submit samples for protein profiling, with typical turnaround times of one week. Pricing is variable, tailored to the specific requirements of each client, and the company also provides subscription-based access to its platform for ongoing collaborations. The company aims to develop new products that build on its existing nELISA technology, with a focus on addressing evolving market demands. Specific regions targeted for expansion include Europe and Asia, with initiatives set to roll out in the coming years, further establishing Nomic Bio's presence in the global proteomics market.
Who invested in Nomic Bio
6 investors across 2 rounds
See all investors in Nomic Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nomic Bio
Who invested in Nomic Bio?
Nomic Bio has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nomic Bio raised?
Nomic Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nomic Bio last raise money?
Nomic Bio's most recent round on record is a Series B, in Sep 2024.
What does Nomic Bio do?
Founded in 2018 in Montreal, Canada, Nomic Bio focuses on innovative proteomics solutions.
Where is Nomic Bio headquartered?
Nomic Bio is headquartered in Montreal, Canada.
Which VCs invest in companies like Nomic Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nomic Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nomic Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.